Physician profile
Michael K Ryan
NPI 1124314612
$249,255.61
in general payments reported to CMS, 2019-2025
16 companies · $55K in 2025
The $55K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,868 · 2020: $1,049 · 2021: $15K · 2022: $53K · 2023: $25K · 2024: $98K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $87K · Acquisitions: $62K · Consulting Fee: $14K · Travel and Lodging: $13K · Food and Beverage: $2,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $86,656.64 |
| Acquisitions | $62,094.55 |
| Consulting Fee | $13,768.75 |
| Travel and Lodging | $12,976.56 |
| Food and Beverage | $2,565.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $145,310.98 | 2019-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $97,368.57 | 2021-2024 | |
| True North Surgical INC | $1,622.30 | 2024-2025 | |
| Reel Surgical, INC. | $1,200.00 | 2021 | |
| Linvatec Corporation | $1,032.73 | 2019-2021 | |
| Joint Restoration Foundation, INC. | $1,000.00 | 2025 | |
| Prime Surgical, LLC | $711.25 | 2020-2023 | |
| Stryker Corporation | $306.64 | 2021 | |
| Smith+Nephew, INC. | $205.18 | 2019-2021 | |
| Horizon Therapeutics Plc | $169.40 | 2020-2021 | |
| Djo, LLC | $149.47 | 2019 | |
| Nutech Spine, INC. | $78.64 | 2019 | |
| Medacta USA, INC. | $39.86 | 2025 | Mypao |
| Avanos Medical | $25.79 | 2023 | Grpro 2.1 |
| Acumed LLC | $23.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.